MedPath
HSA Approval

APO-ALLOPURINOL TABLET 300 mg

SIN06247P

APO-ALLOPURINOL TABLET 300 mg

APO-ALLOPURINOL TABLET 300 mg

June 13, 1991

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

M04AA01

allopurinol

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APOTEX INC

Active Ingredients

ALLOPURINOL

300 mg

Allopurinol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-ALLOPURINOL TABLET 300 mg - HSA Approval | MedPath